Ophthalmology · Rancho Cordova, CA
NPI
1063439776
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
11216 Trinity River Dr
Rancho Cordova, CA, 95670
Phone (916) 635-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$212K
1,465 services
Medicare patients, 2024
631
Average age 74
Drug cost, 2024
$455K
4,021 prescriptions
Company payments, 2025
$86K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph R Martel was code 76519 (ultrasound - nonspecific), 231 times for 197 patients. In total Joseph R Martel billed 1,465 services in 28 codes, and Medicare paid $212K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 76519 Ultrasound - Nonspecific | Office | 231 | 197 | $55.80 | $13K |
| 99214 Office E&M - Established | Office | 227 | 204 | $88.68 | $20K |
| 92250 Angiography | Office | 211 | 193 | $26.04 | $5,494 |
| 66984 Cataract Surgery | Facility | 178 | 159 | $477.47 | $85K |
| 92014 Ophthalmological E&M | Office | 137 | 130 | $90.53 | $12K |
| 92012 Ophthalmological E&M | Office | 102 | 86 | $65.10 | $6,640 |
| 99215 Office E&M - Established | Office | 96 | 95 | $129.16 | $12K |
| 99204 Office E&M - New | Office | 69 | 69 | $127.14 | $8,772 |
| 99205 Office E&M - New | Office | 54 | 54 | $140.45 | $7,584 |
| 92004 Ophthalmological E&M | Office | 50 | 50 | $87.68 | $4,384 |
| 66821 Cataract Surgery | Office | 33 | 33 | $296.83 | $9,796 |
| 66982 Cataract Surgery | Facility | 31 | 29 | $653.83 | $20K |
| 99213 Office E&M - Established | Office | 20 | 18 | $76.91 | $1,538 |
By year: 2022 $216K for 1,657 services; 2023 $175K for 1,344 services; 2024 $212K for 1,465 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph R Martel prescribed most often to Medicare patients was Prednisolone Acetate, with 698 prescriptions and refills. In total Joseph R Martel wrote 4,021 Medicare prescriptions that cost $455K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 698 | 1,266 | 370 | $25K |
| Moxifloxacin Moxifloxacin Hcl | 425 | 426 | 279 | $9,889 |
| Azelastine Hcl Generic | 275 | 339 | 86 | $4,604 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 268 | 432 | 73 | $3,217 |
| Latanoprost Generic | 243 | 415 | 59 | $2,229 |
| Timolol Maleate Generic | 202 | 358 | 60 | $14K |
| Erythromycin Erythromycin Base | 174 | 180 | 75 | $1,991 |
| Lumigan Bimatoprost | 162 | 269 | 45 | $80K |
| Ketorolac Tromethamine Generic | 159 | 179 | 119 | $2,334 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 152 | 154 | 96 | $1,408 |
| Cyclopentolate Hcl Generic | 105 | 108 | 97 | $489 |
| Vyzulta Latanoprostene Bunod | 103 | 134 | 27 | $40K |
| Diclofenac Sodium Generic | 90 | 93 | 63 | $697 |
| Bromfenac Sodium Generic | 88 | 111 | 64 | $17K |
| Bacitracin Generic | 80 | 86 | 47 | $7,907 |
Brand drugs: 1,692 claims; generic drugs: 2,329 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph R Martel $86K ($876 in general payments such as food, travel and fees and $85K for research) from 14 companies. The largest payer was Argenx US, Inc. with $85K.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 18 | $85K |
| Alcon Vision LLC ALC | 15 | $328 |
| Bausch & Lomb Americas Inc. BLCO | 7 | $138 |
| Amgen Inc. AMGN | 4 | $79.67 |
| Harrow Eye, LLC | 2 | $65.05 |
| Abbvie Inc. ABBV | 3 | $54.79 |
| Genentech USA, Inc. ROG.SW | 2 | $54.18 |
| Astellas Pharma US Inc 4503.T | 2 | $37.69 |
| Dompe US, Inc. | 1 | $34.39 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $30.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.